Safety And Overall Survival (Os) In Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Treated With Radium-223 (Ra-223) Plus Subsequent Taxane Therapy.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要